Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06231537 | Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals | completed | N/A | 1,152 | Universidade Federal do Rio de JaneiroOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT03355560 | Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy | completed | Phase 2 | 39 | Trisha Wise-DraperOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT03506451 | PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study(PaRTNer) | completed | N/A | 60 | Duke UniversityOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04565457 | A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality | completed | N/A | 43 | University of Colorado, DenverOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT05256238 | Effect of Exercise in Head and Neck Cancer Patients(EffEx-HN) | completed | N/A | 133 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT06576908 | Evaluation of On-Couch CBCT Image Quality | completed | N/A | 46 | Varian, a Siemens Healthineers CompanyINDUSTRY | 1 | May 6, 2026 | clinicaltrials |
| NCT03848286 | KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma | completed | Phase 2 | 153 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.INDUSTRY | 1 | May 5, 2026 | clinicaltrials |
| NCT04665843 | A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck(SKYSCRAPER-09) | completed | Phase 2 | 123 | Hoffmann-La RocheINDUSTRY | 13 | May 5, 2026 | clinicaltrials |
| NCT05117775 | Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence. HNC-TACTIC.(HNC-TACTIC) | completed | — | 10,000 | Savana ResearchNETWORK | 1 | May 1, 2026 | clinicaltrials |
| NCT05120947 | Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers(HART-HN) | completed | N/A | 18 | Medical College of WisconsinOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT05265819 | Effect of Exergaming Exercises and Mediterranean Diet on Thyroid Cancer Patients Following Total Thyroidectomy | completed | N/A | 80 | Nabil Mahmoud Ismail Abdel-AalOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT06432998 | Perineal Massage in Women With Gynecological Cancer | completed | N/A | 35 | University of AlcalaOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT02633202 | Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era | completed | Phase 3 | 338 | Sun Yat-sen UniversityOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT03818061 | Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck(ATHENA) | completed | Phase 2 | 33 | Centre Leon BerardOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT05213884 | The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC | completed | Phase 2 | 39 | Chongqing University Cancer HospitalOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT02546895 | Prospective Registration of Head and Neck Cancer | completed | — | 2,000 | Samsung Medical CenterOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT04447456 | Comparison of Voice Results at 5 Years of Treatment of Glottic Squamous Cell Carcinoma T1 by Surgery Versus Radiotherapy(VO Qual) | completed | — | 41 | University Hospital, LilleOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT07543887 | Selpercatinib and Body Composition(EECRTKI) | completed | — | 15 | University of PisaOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT03621696 | Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)"(MINT) | completed | Phase 2 | 63 | Washington University School of MedicineOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07029373 | Plasma Calcitonin Gene-Related Peptide (CGRP) Levels in Patients With Head and Neck Malignancies Undergoing Radiotherapy | completed | — | 23 | West China HospitalOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07247526 | Effect of Foot Bath on Anxiety and Physiological Parameters | completed | N/A | 100 | Trakya UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT03881488 | Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies | completed | Phase 1 | 100 | Compass TherapeuticsINDUSTRY | 1 | Apr 17, 2026 | clinicaltrials |
| NCT03574792 | Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy | completed | Phase 2 | 62 | Roswell Park Cancer InstituteOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT04449445 | Perioperative Nutritional Optimization in Head and Neck Cancer Patients | completed | N/A | 4 | University of Illinois at ChicagoOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT04704453 | Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain.(TEC-ORL) | completed | Phase 2 | 13 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT02649569 | Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer | completed | — | 41 | Montefiore Medical CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT03102229 | Real-time Activity Monitoring to Prevent Admissions During RadioTherapy(RAMPART) | completed | N/A | 40 | Montefiore Medical CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT03115398 | A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery | completed | N/A | 166 | Montefiore Medical CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05461430 | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)(TraveraRTGx) | completed | — | 72 | Travera IncINDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06676943 | Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection(eXcision) | completed | N/A | 57 | University Hospitals Coventry and Warwickshire NHS TrustOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT03236935 | Phase Ib of L-NMMA and Pembrolizumab | completed | Phase 1 | 12 | The Methodist Hospital Research InstituteOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT05077709 | IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC | completed | Phase 2 | 63 | IO BiotechINDUSTRY | 3 | Apr 8, 2026 | clinicaltrials |
| NCT05694819 | Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) | completed | Phase 2 | 57 | National Cancer Center Hospital EastOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT05563480 | TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma | completed | Phase 2 | 47 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Apr 7, 2026 | clinicaltrials |
| NCT02510859 | Nutrition and Life QUality Patients With Head and Neck Cancers(NUQUE2) | completed | N/A | 117 | University Hospital, CaenOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT03370276 | Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | completed | Phase 1 / Phase 2 | 95 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05628883 | Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma | completed | Phase 1 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05673577 | Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients | completed | Phase 2 | 41 | Fudan UniversityOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05315570 | Big Data for Quality of Life in Head and Neck Cancer(BD4QoL) | completed | N/A | 410 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 2 | Apr 1, 2026 | clinicaltrials |
| NCT05561920 | Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients | completed | — | 55 | Osijek University HospitalOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT05696288 | Conventional Oxygen Therapy Versus Continuous Transnasal High Flow Oxygen Therapy for Head and Neck Diagnostic Panendoscopy Under General Anesthesia in Spontaneous Ventilation(OPTINOSE) | completed | N/A | 160 | Centre Antoine LacassagneOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT02517125 | Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors(TORS) | completed | N/A | 100 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT06826170 | Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)(HYPOADENO) | completed | N/A | 25 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT01783587 | Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer | completed | Phase 1 | 29 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT05418842 | Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial(FIT4TREAT) | completed | N/A | 47 | Associacao de Investigacao de Cuidados de Suporte em OncologiaOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT04074642 | OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.(FIRST) | completed | N/A | 21 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT03217188 | Proton Re-Irradiation for Recurrent Head and Neck Cancer | completed | Phase 2 | 87 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 23, 2026 | clinicaltrials |
Data updated 22 days agoSource updated May 7, 2026source: clinicaltrials